The Citizen

The future is what we make of it

As a chemist my main objective is to find solutions to scientific problems. I am persistent when it comes to solving problems and the moments of true discovery are breathtaking. That´s why I became a scientist in the first place. My greatest scientific achievement to date is the development of an automated oligosaccharide synthesis platform that now enables us to rapidly fuel a growing pipeline of vaccine candidates against neglected diseases like malaria and a host of bacterial diseases including the deadliest bacterium in the third world: Streptococcus pneumoniae.

But there is tragedy in these scientific triumphs. The people dying from these diseases are poor, and because they cannot pay for vaccines the pharmaceutical industry does not produce them. It´s as simple and cruel as that. At the end of the day my scientific results might not help these people to survive, although they could.

Something is deeply wrong in this picture. Because market forces rule supreme in our world, people have to die. Don´t get me wrong, I don´t blame the companies and have even started two myself. The task of companies is to make money.

Universities, parliaments and companies are called upon to find solutions to this problem. All of us in science and industry have to become active and find new ways such that the kowledge we produce can help all humans in need of it. If the reality is different, it needs to be changed.

I will do my very best to solve this „scientific problem“ too, together with likeminded individuals from various treats of life. I am convinded together we can make a difference. I hope I can tell you about first successes in the very near future - and invite you to join the effort.

Further Informations:
The Tesfa-ILG "Hope for Africa" Foundation

News:

After years of planning and preparation began mid-September 2011, the production of LLIN factory in Ethiopia. The LLIN Produced mosquitoes nets to protect against malaria. First, with about 125 seamstresses started in single, to continuously expand production up to 400 people. Overall, the annual production amounted to 2 million malaria nets.

The official inauguration ceremony will take place in mid-October 2011.

LLIN Company Ethopia LLIN Company Ethopia LLIN Company Ethopia